TrialBlood cancer journal2022

An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial).

Huai-Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.